1
|
Abdelmonem R, Al-Samadi IEI, El Nashar RM, Jasti BR, El-Nabarawi MA. Fabrication of nanostructured lipid carriers ocugel for enhancing Loratadine used in treatment of COVID-19 related symptoms: statistical optimization, in-vitro, ex-vivo, and in-vivo studies evaluation. Drug Deliv 2022; 29:2868-2882. [PMID: 36065090 PMCID: PMC9448409 DOI: 10.1080/10717544.2022.2115164] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
Abstract
Loratadine (LORA), is a topical antihistamine utilized in the treatment of ocular symptoms of COVID-19. The study aimed to develop a Loratadine Nanostructured Lipid Carriers Ocugel (LORA-NLCs Ocugel), enhance its solubility, trans-corneal penetrability, and bioavailability. full-factorial design was established with 24 trials to investigate the impact of several variables upon NLCs properties. LORA-NLCs were fabricated by using hot melt emulsification combined with high-speed stirring and ultrasonication methods. All obtained formulae were assessed in terms of percent of entrapment efficiency (EE%), size of the particle (PS), zeta potential (ZP), as well as in-vitro release. Via using Design Expert® software the optimum formula was selected, characterized using FTIR, Raman spectroscopy, and stability studies. Gel-based of optimized LORA-NLCs was prepared using 4% HPMC k100m which was further evaluated in terms of physicochemical properties, Ex-vivo, and In-vivo studies. The optimized LORA-NLCs, comprising Compritol 888 ATO®, Labrasol®, and Span® 60 showed EE% of 95.78 ± 0.67%, PS of 156.11 ± 0.54 nm, ZP of -40.10 ± 0.55 Mv, and Qh6% of 99.67 ± 1.09%, respectively. Additionally, it illustrated a spherical morphology and compatibility of LORA with other excipients. Consequently, gel-based on optimized LORA-NLCs showed pH (7.11 ± 0.52), drug content (98.62%± 1.31%), viscosity 2736 cp, and Q12% (90.49 ± 1.32%). LORA-NLCs and LORA-NLCs Ocugel exhibited higher ex-vivo trans-corneal penetrability compared with the aqueous drug dispersion. Confocal laser scanning showed valuable penetration of fluoro-labeled optimized formula and LORA-NLCs Ocugel through corneal. The optimized formula was subjected to an ocular irritation test (Draize Test) that showed the absence of any signs of inflammation in rabbits, and histological analysis showed no effect or damage to rabbit eyeballs. Cmax and the AUC0-24 were higher in LORA-NLCs Ocugel compared with pure Lora dispersion-loaded gel The research findings confirmed that NLCs could enhance solubility, trans-corneal penetrability, and the bioavailability of LORA.
Collapse
Affiliation(s)
- Rehab Abdelmonem
- Department of Industrial Pharmacy, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology, Giza, Egypt
| | - Inas Essam Ibrahim Al-Samadi
- Department of Industrial Pharmacy, College of Pharmaceutical Sciences and Drug Manufacturing, Misr University for Science and Technology, Giza, Egypt
| | - Rasha M El Nashar
- Department of Chemistry, Faculty of Science, Cairo University, Giza, Egypt
| | - Bhaskara R Jasti
- Department of Pharmaceutics and Medicinal Chemistry, Thomas J. Long School of Pharmacy and Healthy Science-Pacific University, Stockton, CA, USA
| | - Mohamed A El-Nabarawi
- Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University Giza, Giza, Egypt
| |
Collapse
|
2
|
Yasunaga T, Fukuoka T, Yamaguchi A, Ogawa N, Yamamoto H. Microtaggant Technology for Ensuring Traceability of Pharmaceutical Formulations: Potential for Anti-counterfeiting Measures, Distribution and Medication Management. YAKUGAKU ZASSHI 2022; 142:1255-1265. [DOI: 10.1248/yakushi.22-00147] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- Toshiya Yasunaga
- Laboratory of Pharmaceutical Engineering, School of Pharmacy, Aichi Gakuin University
| | | | - Akinobu Yamaguchi
- Laboratory of Advanced Science and Technology for Industry, University of Hyogo
| | - Noriko Ogawa
- Laboratory of Pharmaceutical Engineering, School of Pharmacy, Aichi Gakuin University
| | - Hiromitsu Yamamoto
- Laboratory of Pharmaceutical Engineering, School of Pharmacy, Aichi Gakuin University
| |
Collapse
|
3
|
Ren J, Mao S, Lin J, Xu Y, Zhu Q, Xu N. Research Progress of Raman Spectroscopy and Raman Imaging in Pharmaceutical Analysis. Curr Pharm Des 2022; 28:1445-1456. [PMID: 35593344 DOI: 10.2174/1381612828666220518145635] [Citation(s) in RCA: 6] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2021] [Accepted: 03/03/2022] [Indexed: 11/22/2022]
Abstract
The analytical investigation of the pharmaceutical process monitors the critical process parameters of the drug, beginning from its development until marketing and postmarketing, and appropriate corrective action can be taken to change the pharmaceutical design at any stage of the process. Advanced analytical methods, such as Raman spectroscopy, are particularly suitable for use in the field of drug analysis, especially for qualitative and quantitative work, due to the advantages of simple sample preparation, fast, nondestructive analysis speed, and effective avoidance of moisture interference. Advanced Raman imaging techniques have gradually become a powerful alternative method for monitoring changes in polymorph distribution and active pharmaceutical ingredient distribution in drug processing and pharmacokinetics. Surface-enhanced Raman spectroscopy (SERS) has also solved the inherent insensitivity and fluorescence problems of Raman, which has made good progress in the field of illegal drug analysis. This review summarizes the application of Raman spectroscopy and imaging technology, which are used in the qualitative and quantitative analysis of solid tablets, quality control of the production process, drug crystal analysis, illegal drug analysis, and monitoring of drug dissolution and release in the field of drug analysis in recent years.
Collapse
Affiliation(s)
- Jie Ren
- College of Pharmaceutical Science, Institute of Drug Development & Chemical Biology, Zhejiang University of Technology, Hangzhou 310014, Zhejiang, People\'s Republic of China
| | - Shijie Mao
- College of Pharmaceutical Science, Institute of Drug Development & Chemical Biology, Zhejiang University of Technology, Hangzhou 310014, Zhejiang, People\'s Republic of China
| | - Jidong Lin
- College of Pharmaceutical Science, Institute of Drug Development & Chemical Biology, Zhejiang University of Technology, Hangzhou 310014, Zhejiang, People\'s Republic of China
| | - Ying Xu
- College of Pharmaceutical Science, Institute of Drug Development & Chemical Biology, Zhejiang University of Technology, Hangzhou 310014, Zhejiang, People\'s Republic of China
| | - Qiaoqiao Zhu
- College of Pharmaceutical Science, Institute of Drug Development & Chemical Biology, Zhejiang University of Technology, Hangzhou 310014, Zhejiang, People\'s Republic of China
| | - Ning Xu
- College of Pharmaceutical Science, Institute of Drug Development & Chemical Biology, Zhejiang University of Technology, Hangzhou 310014, Zhejiang, People\'s Republic of China
| |
Collapse
|
4
|
Stępień KA, Giebułtowicz J. Application of Liquid Chromatography Coupled to Mass Spectrometry in Quality Assessment of Dietary Supplements-A Case Study of Tryptophan Supplements: Release Assay, Targeted and Untargeted Studies. Pharmaceuticals (Basel) 2022; 15:448. [PMID: 35455446 PMCID: PMC9031539 DOI: 10.3390/ph15040448] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/17/2022] [Revised: 03/29/2022] [Accepted: 03/31/2022] [Indexed: 11/27/2022] Open
Abstract
Dietary supplements are widely consumed in the EU and the USA. Based on their similarity to pharmaceuticals, consumers mistakenly believe that dietary supplements have also been approved for safety and efficacy. However, in the absence of mandatory testing, data on supplement quality is scarce. Thus, we applied liquid chromatography coupled with tandem mass spectrometry to analyse the quality of dietary supplements containing tryptophan (Trp). We examined 22 supplements in tablets or capsules, produced in the USA, Great Britain, Germany, France, Czech Republic, and Poland. Trp release, crucial for bioavailability and efficiency, was assessed. Additionally, we performed a qualitative analysis of the main ingredient and screened for contaminants. Among the contaminants, we detected Trp's metabolites, condensation products of Trp and carbonyl compounds, Trp degradation products, degradation products of kynurenine, and other contaminants such as glucosamine and melatonin. The main ingredient content was in the range of 55-100% in capsules and 69-87% in tablets. Surprisingly, almost no Trp release was noted from some supplements. Our study confirms the need to advance research on supplements. We believe that the high-quality analysis of supplements based on reliable analytical techniques will be an important contribution to the discussion on the regulatory framework of these products.
Collapse
Affiliation(s)
| | - Joanna Giebułtowicz
- Department of Bioanalysis and Drugs Analysis, Faculty of Pharmacy, Medical University of Warsaw, 1 Banacha, 02-097 Warsaw, Poland;
| |
Collapse
|
5
|
Wang K, Wu S, Zhao J, Zhou M, Li G, Wang D, Lin L. Dual-mode spectrum of transmission and fluorescence using single ultraviolet LED light source and their application in analyzing total bilirubin in serum. SPECTROCHIMICA ACTA. PART A, MOLECULAR AND BIOMOLECULAR SPECTROSCOPY 2022; 264:120305. [PMID: 34455381 DOI: 10.1016/j.saa.2021.120305] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/01/2021] [Revised: 08/16/2021] [Accepted: 08/17/2021] [Indexed: 06/13/2023]
Abstract
In order to improve the accuracy of spectral analysis of complex solutions, based on the "M + N" theory, this paper proposes to use single (365 nm ± 5 nm) ultraviolet LED as emission light to detect transmission spectrum and excited fluorescence spectrum. Taking the total bilirubin in serum as the measurement object, the dual-mode spectrum of transmission and fluorescence about serum is collected, which increases the amount of information. In order to verify the effectiveness of the method proposed in this paper, the transmission and fluorescence spectra of the samples were also collected. Then three models of total bilirubin concentration are established by transmission spectrum, fluorescence spectrum and dual-mode spectrum of transmission and fluorescence respectively. Through the comparison of the parameters of the three models, the model established by dual-mode spectrum of transmission and fluorescence is good. The Rc of the model is 0.91 and the RMSEC is 3.00 (μmol/L). The Rp is 0.92, the RMSEP is 3.53 (μmol/L). Compared with transmission spectrum modeling and fluorescence spectrum modeling, the RMSEP of dual-mode spectrum modeling was reduced by 34.8% and 22.6% respectively. The experimental results show that the measurement method of dual-mode spectrum of transmission and fluorescence by using a single ultraviolet light source proposed in this paper based on the "M + N" theory increases the information of solution composition, which provides a new method for the analysis of the same characteristic components.
Collapse
Affiliation(s)
- Kang Wang
- Tianjin University, State Key Laboratory of Precision Measurement Technology and Instruments, China.
| | | | - Jing Zhao
- Tianjin University of Traditional Chinese Medicine, China
| | - Mei Zhou
- East China Normal University, China.
| | - Gang Li
- Tianjin University, State Key Laboratory of Precision Measurement Technology and Instruments, China.
| | - Dan Wang
- Tianjin University, State Key Laboratory of Precision Measurement Technology and Instruments, China.
| | - Ling Lin
- Tianjin University, State Key Laboratory of Precision Measurement Technology and Instruments, China.
| |
Collapse
|
6
|
Mititelu M, Moroșan E, Nicoară AC, Secăreanu AA, Musuc AM, Atkinson I, Pandele Cusu J, Nițulescu GM, Ozon EA, Sarbu I, Balaci TD. Development of Immediate Release Tablets Containing Calcium Lactate Synthetized from Black Sea Mussel Shells. Mar Drugs 2022; 20:md20010045. [PMID: 35049900 PMCID: PMC8778094 DOI: 10.3390/md20010045] [Citation(s) in RCA: 9] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2021] [Revised: 12/27/2021] [Accepted: 12/31/2021] [Indexed: 02/05/2023] Open
Abstract
Nowadays, the use of marine by-products as precursor materials has gained great interest in the extraction and production of chemical compounds with suitable properties and possible pharmaceutical applications. The present paper presents the development of a new immediate release tablet containing calcium lactate obtained from Black Sea mussel shells. Compared with other calcium salts, calcium lactate has good solubility and bioavailability. In the pharmaceutical preparations, calcium lactate was extensively utilized as a calcium source for preventing and treating calcium deficiencies. The physical and chemical characteristics of synthesized calcium lactate were evaluated using Fourier Transform Infrared Spectroscopy, X-ray diffraction analysis and thermal analysis. Further, the various pharmacotechnical properties of the calcium lactate obtained from mussel shells were determined in comparison with an industrial used direct compressible Calcium lactate DC (PURACAL®). The obtained results suggest that mussel shell by-products are suitable for the development of chemical compounds with potential applications in the pharmaceutical domain.
Collapse
Affiliation(s)
- Magdalena Mititelu
- Department of Clinical Laboratory and Food Safety, Faculty of Pharmacy, Carol Davila University of Medicine and Pharmacy, 6 Traian Vuia Street, 020945 Bucharest, Romania; (M.M.); (E.M.)
| | - Elena Moroșan
- Department of Clinical Laboratory and Food Safety, Faculty of Pharmacy, Carol Davila University of Medicine and Pharmacy, 6 Traian Vuia Street, 020945 Bucharest, Romania; (M.M.); (E.M.)
| | - Anca Cecilia Nicoară
- Department of Pharmaceutical Technology and Biopharmacy, Faculty of Pharmacy, Carol Davila University of Medicine and Pharmacy, 6 Traian Vuia Street, 020945 Bucharest, Romania; (A.C.N.); (A.A.S.); (T.D.B.)
| | - Ana Andreea Secăreanu
- Department of Pharmaceutical Technology and Biopharmacy, Faculty of Pharmacy, Carol Davila University of Medicine and Pharmacy, 6 Traian Vuia Street, 020945 Bucharest, Romania; (A.C.N.); (A.A.S.); (T.D.B.)
| | - Adina Magdalena Musuc
- “Ilie Murgulescu” Institute of Physical Chemistry, 202 Spl. Independentei, 060021 Bucharest, Romania; (I.A.); (J.P.C.)
- Correspondence: (A.M.M.); (G.M.N.); (E.A.O.); (I.S.)
| | - Irina Atkinson
- “Ilie Murgulescu” Institute of Physical Chemistry, 202 Spl. Independentei, 060021 Bucharest, Romania; (I.A.); (J.P.C.)
| | - Jeanina Pandele Cusu
- “Ilie Murgulescu” Institute of Physical Chemistry, 202 Spl. Independentei, 060021 Bucharest, Romania; (I.A.); (J.P.C.)
| | - George Mihai Nițulescu
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Carol Davila University of Medicine and Pharmacy, 6 Traian Vuia Street, 020945 Bucharest, Romania
- Correspondence: (A.M.M.); (G.M.N.); (E.A.O.); (I.S.)
| | - Emma Adriana Ozon
- Department of Pharmaceutical Technology and Biopharmacy, Faculty of Pharmacy, Carol Davila University of Medicine and Pharmacy, 6 Traian Vuia Street, 020945 Bucharest, Romania; (A.C.N.); (A.A.S.); (T.D.B.)
- Correspondence: (A.M.M.); (G.M.N.); (E.A.O.); (I.S.)
| | - Iulian Sarbu
- Department of Pharmaceutical Physics and Biophysics, Drug Industry and Pharmaceutical Biotechnologies, Faculty of Pharmacy, “Titu Maiorescu” University, 004051 Bucharest, Romania
- Correspondence: (A.M.M.); (G.M.N.); (E.A.O.); (I.S.)
| | - Teodora Dalila Balaci
- Department of Pharmaceutical Technology and Biopharmacy, Faculty of Pharmacy, Carol Davila University of Medicine and Pharmacy, 6 Traian Vuia Street, 020945 Bucharest, Romania; (A.C.N.); (A.A.S.); (T.D.B.)
| |
Collapse
|